We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $109M
1-Year Est. Return 97.13%
This Fund
S&P 500
This Quarter Est. Return
+34.11%
1 Year Est. Return
+97.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$109M
AUM Growth
+$6.53M
Cap. Flow
-$6.26M
Cap. Flow %
-5.72%
Top 10 Hldgs %
32.08%
Holding
212
New
75
Increased
28
Reduced
43
Closed
29

Sector Composition

Rank Sector Weight
1 Healthcare 27.11%
2 Consumer Discretionary 14.33%
3 Financials 12.51%
4 Miscellaneous 10.11%
5 Real Estate 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
76
CALL
Microsoft
MSFT
$3.68T
$373K 0.34%
+1,000
New +$405K
DCH
77
Dauch Corp
DCH
$1.56B
$369K 0.34%
+68,000
New +$413K
SEER icon
78
Seer Inc
SEER
$108M
$369K 0.34%
222,000
+37,698
+20% +$68.4K
PS
79
Pershing Square
PS
$15.1B
$361K 0.33%
+11,000
New +$400K
STRS
80
DELISTED
STRATUS PPTYS INC
STRS
$361K 0.33%
12,546
ABEO icon
81
Abeona Therapeutics
ABEO
$312M
$359K 0.33%
58,100
-1,900
-3% -$10.4K
BHR
82
Braemar Hotels & Resorts
BHR
$128M
$351K 0.32%
162,567
-59,433
-27% -$142K
FERA
83
Fifth Era Acquisition Corp I
FERA
$349K 0.32%
33,458
+2,468
+8% +$25.6K
ACDC icon
84
ProFrac Holding
ACDC
$958M
$346K 0.32%
+59,578
New +$401K
DMIIU
85
Drugs Made In America Acquisition II Corp Unit
DMIIU
$331K 0.3%
32,551
-23,061
-41% -$233K
PRTH icon
86
Priority Technology Holdings
PRTH
$501M
$327K 0.3%
49,000
-10,000
-17% -$57.9K
EGHA
87
EGH Acquisition Corp
EGHA
$213M
$324K 0.3%
+31,474
New +$324K
DBCA
88
D. Boral Acquisition I Corp
DBCA
$434M
$321K 0.29%
+32,193
New +$320K
XRXDW
89
Xerox Holdings Corp Warrants
XRXDW
$25.8M
$313K 0.29%
+100,000
New +$27.2K
RTAC
90
Renatus Tactical Acquisition Corp I
RTAC
$326M
$311K 0.28%
29,659
-6,123
-17% -$63.6K
NFBK
91
DELISTED
Northfield Bancorp
NFBK
$309K 0.28%
+21,000
New +$297K
NVRI icon
92
Enviri
NVRI
$629M
$307K 0.28%
14,000
-14,000
-50% -$280K
TMQ
93
Trilogy Metals
TMQ
$579M
$305K 0.28%
87,000
OTGAU
94
OTG Acquisition Corp I Unit
OTGAU
$284K 0.26%
27,520
-23,285
-46% -$239K
FDMT icon
95
4D Molecular Therapeutics
FDMT
$723M
$279K 0.25%
20,965
-10,500
-33% -$102K
LSTA icon
96
Lisata Therapeutics
LSTA
$15M
$275K 0.25%
81,000
+6,000
+8% +$21.4K
WEAV icon
97
Weave Communications
WEAV
$585M
$274K 0.25%
+45,700
New +$249K
EXEL icon
98
Exelixis
EXEL
$14B
$272K 0.25%
5,000
FWRD icon
99
CALL
Forward Air
FWRD
$556M
$272K 0.25%
20,100
KOYNU
100
CSLM Digital Asset Acquisition Corp III Units
KOYNU
$269K 0.25%
26,092
-22,852
-47% -$234K

Similar funds

Rangeley Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Rangeley Capital held 212 positions worth $109M, up 6.3% from $103M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Rangeley Capital withdrew a net $6.26M in Q2 2026, closing 29 positions and reducing 43 holdings. Its most notable exit was Leggett & Platt, an estimated $2.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Rangeley Capital opened a new position in Nomad Foods worth $1.48M.

  • Rangeley Capital's largest Q2 2026 buy was Nomad Foods: 135,000 shares worth $1.48M.
  • Rangeley Capital added most to Distribution Solutions Group in Q2 2026, an estimated $1.26M increase.
  • Rangeley Capital's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $8.47M.
  • Rangeley Capital fully exited Leggett & Platt in Q2 2026, selling an estimated $2.1M.
  • Rangeley Capital's ten largest holdings make up 32% of its $109M portfolio in Q2 2026.
  • Rangeley Capital opened 75 new positions and closed 29 in Q2 2026.
  • Rangeley Capital's portfolio value rose 6.3% quarter-over-quarter to $109M.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.